(NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the pharmacy and nursing care delivery model, today announced results for its second quarter ...

Management raised full-year 2025 guidance for both revenue and adjusted EPS, supported by strong operational cash flow and robust volume growth. Organic volume growth remained modest at 2.1%, with ...